Articles On Optiscan Imaging (ASX:OIL)

In February, ASX fintech stocks were winners, losers and winners again. The benchmark ASX 200 index made a 1 per cent gain for month – despite a late month drop — driven largely by favourite fintech Zip (ASX:Z1P) +43%, as well as Virgin Mon...

The Optiscan Imaging Limited (ASX: OIL) share price took flight today as the company announced the start of an important study. Shares in the innovative health researcher were swapping hands for 12.5 cents, up 13.6%, at the close of trade...

The Optiscan Imaging Limited (ASX: OIL) share price is climbing higher today after a positive announcement on a product order. At the time of writing, the Optiscan share price is up 4.3% higher to 12 cents. In comparison, the All Ordinarie...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The health sector made a bit of progress over the last fortnight, with 64 small-cap life sciences gaining ground and just 52 losing it. Another 15 companies were flat....

A quick wrap of the ASX’s key winners and losers on Monday, September 7. Data is taken after the market closes at 4pm AEST. Stocks highlighted in yellow made market-moving announcements during the day. Today 847 stocks rose, 575 declined an...

Our summary of Optiscan Imaging Ltd's recent announcement What's happened? Optiscan Imaging Limited (ASX:OIL) has been awarded a grant of almost $1 million by the Australian Government, which will help fund a trial to improve screening, dia...

A quick wrap of the key winners and losers on Friday, June 26. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 907 stocks rose, 484 declined and 722 were...

Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 61 were in positive territory over the last fortnight, 10 were flat and 66 saw their share prices fall. Code Name...

Cancer-fighting biotech Immutep (ASX:IMM) has risen off 10-year-long lows after flagging a payment of $7.4m from British pharma giant GSK. Immutep shares got a 14 per cent boost to 2.5c, after closing at 2.2c on Friday. The share price has...

Medical equipment maker Optiscan Imaging (ASX: OIL) has achieved a significant milestone as part of its overarching development strategy after its cutting-edge “virtual biopsy technology” was selected for use in an oral cancer clinical tria...